Inhibition of voltage-gated Ca2+ channels by antazoline.
Didier Milhaud, Laurent Fagni, Joël Bockaert, Mireille Lafon-Cazal
Index: Neuroreport 13(14) , 1711-4, (2002)
Full Text: HTML
Abstract
We showed recently that imidazolines exert neuroprotection against hypoxia and NMDA toxicity in cerebellar and striatal neuronal cultures, through a voltage-dependent blockade of glutamatergic NMDA receptors. Here, we report that in striatal neuronal cultures from mouse embryos the imidazoline compound, antazoline, inhibits voltage-gated Ca2+ channels by acting at a phencyclidine-like site. This effect was fast, fully reversible, voltage-dependent and predominant on P/Q- and N-type Ca2+ channels. Taken together, these results suggest that imidazolines may elicit neuroprotective effects also by decreasing the release of glutamate through inhibition of presynaptic Ca2+ channels.Copyright 2002 Lippincott Williams & Wilkins
Related Compounds
Related Articles:
2010-01-01
[Eur. J. Ophthalmol. 20(5) , 811-8, (2010)]
2010-01-01
[J. AOAC Int. 93(6) , 1995-2001, (2010)]
1998-05-01
[Analyst 123(5) , 1079-84, (1998)]
2006-01-01
[Chem. Pharm. Bull. 54(1) , 119-22, (2006)]
2012-01-01
[Trials 13 , 162, (2012)]